Oocyte cryopreservation in oncological patients

Eleonora Porcu1, Raffaella Fabbri, Giuseppe Damiano

  • 1Department of Obstetrics and Gynecology, Infertility and IVF Centre, University of Bologna, Via Massarenti 13, 40138 Bologna, Italy. porcu@med.unibo.it

Insights

Oocyte cryopreservation offers a viable fertility preservation option for cancer patients undergoing chemotherapy or radiotherapy. Stored eggs remain viable for conception even after several years in liquid nitrogen.

Area of Science:

  • Reproductive Medicine
  • Oncology
  • Cryobiology

Background:

  • Chemotherapy and radiotherapy can impair reproductive potential in cancer patients.
  • Sperm cryopreservation is established for male cancer patients.
  • Ovarian function loss is a risk for female cancer patients undergoing treatment.

Purpose of the Study:

  • To evaluate the efficacy of oocyte cryopreservation for oncological patients.
  • To assess the feasibility of fertility preservation in women undergoing cancer treatment.

Main Methods:

  • Oocyte cryopreservation program for 18 patients awaiting cancer treatment (June 1996 - January 2000).
  • Patients received chemotherapy and/or radiotherapy post-oocyte cryopreservation.

Main Results:

  • Oocyte cryopreservation demonstrated to be a practical fertility preservation method.
  • Pregnancies were achieved after several years of oocyte storage.
  • Storage duration did not negatively impact oocyte survival rates.

Conclusions:

  • Oocyte cryopreservation is a pragmatic and effective fertility preservation strategy for oncological patients.
  • Long-term oocyte storage in liquid nitrogen is feasible and successful for achieving pregnancies.